Recent pharmaceutical cases in regulatory and intellectual property law have resulted in developments on several fronts, including:

  • regulatory matters;
  • patent validity and damages;
  • Patented Medicines (Notice of Compliance) Regulations proceedings; and
  • class actions.

In this paper, we review some of the most notable Canadian decisions from 2015 that will continue to impact the legal landscape for the pharmaceutical industry in Canada over the coming year.

Download the brochure here: 2015 Pharma in Brief (pdf 2.15MB)



Practice area:

Industry:

Recent publications

international cargo ship

Publication

Global Affairs Canada releases updated sanctions compliance guidance

In November 2025, the Sanctions Bureau of Global Affairs Canada (GAC) released additional guidance on compliance with Canada’s sanctions regime.

Canada | November 17, 2025

Financial institutions
Collage of brain over circuit board

Publication

The AI trap: What Laprade reveals about risk in investigations, self-disclosure and insolvency

In the evolving landscape of white-collar litigation and insolvency investigations, generative AI is rapidly becoming a tool of choice for legal teams seeking speed, scale, and precision.

Canada | November 17, 2025

Artificial intelligence (AI)
employees walking in modern building

Publication

British Columbia sick note restrictions now in force

As of November 12, 2025, British Columbia employers are prohibited from requesting sick notes for certain health-related employee absences.

Canada | November 14, 2025

Employment and labour
Site search

Subscribe and stay up to date with the latest legal news, information and events . . .

Subscribe now